Popai Health

Popai Health, based in the US, specializes in AI-driven healthcare solutions that enhance care delivery through advanced technology, optimizing patient interactions and operational efficiencies. Founded in 2024 and headquartered in San Francisco, US, Popai Health is focused on developing AI solutions for the healthcare sector. The company raised USD 11. 00 mn in their latest funding round in November 2025, which was co-led by New Enterprise Associates and Team8 Capital.

Popai Health specializes in AI-driven solutions designed to enhance care delivery within the healthcare sector. Their core offering revolves around an advanced platform that processes care management calls, capturing critical information from 100% of patient interactions to improve standardized care, patient outcomes, and operational efficiencies. This platform utilizes natural language processing (NLP) to analyze conversations, enabling automated workflows, actionable insights, and real-time interventions. Popai serves various segments of the healthcare market, including care management teams, call centers, specialty care providers, and pharmacy teams, helping them manage high-risk populations effectively and streamline operational processes.

The solutions are marketed and sold primarily in North America, with potential applicability in other regions where healthcare systems face similar challenges. Popai Health generates revenue through a subscription-based model, providing their AI platform and associated services to healthcare organizations on a recurring basis. Clients typically engage in long-term partnerships, accessing a suite of tools that enhance care coordination and operational efficiency. The transaction structure involves B2B relationships, where healthcare providers subscribe to the platform to automate documentation, streamline workflows, and gain insights from care conversations.

While specific pricing details are proprietary, the platform is bundled with various service tiers to accommodate different organizational needs, thereby aligning costs with the value delivered through improved patient care and operational performance. In November 2025, Popai Health raised USD 11. 00 mn in venture funding to grow its AI platform, improve its technology, and extend adoption among healthcare organizations. The recent funding will enable the company to design and launch new products tailored for the healthcare market and expand its presence into additional geographic regions, ensuring broader access to its innovative solutions.